Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler® real-time PCR

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Kabamba Mukadi, Benoît ^a   Henrivaux, Philippe ^b   Ruelle, Jean ^a   Delferrière, Nicole ^a   Bodéus, Monique ^a   Goubau, Patrick ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Clinique Saint Joseph   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA GLOBIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MALE; PROVIRUS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REBOUND; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; STEADY STATE; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS LOAD; VIRUS TYPING;

EID: 25444515465     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-15     Document Type: Article

References (34)

1. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents [http://aidsinfo.nih.gov/guidelines/]. October 29, 2004
2. Bennett JM, Kaye S, Berry N, Tedder RS: A quantitative PCR method for the assay of HIV-1 provirus load in peripheral blood mononuclear cells. J Virol Methods 1999, 83:11-20.
3. Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, Lloyd AL, Nowak MA, Fauci AS: Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997, 94:13193-13197.
4. Burgard M, Izopet J, Dumon B, Tamalet C, Descamps D, Ruffault A, Vabret A, Bargues G, Mouroux M, Pellegrin I, Ivanoff S, Guisthau O, Calvez V, Seigneurin JM, Rouzioux C: HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment. AIDS Res Hum Retroviruses 2000, 10:1939-1947.
5. De Milito A, Titanji K, Zazzi M: Surrogate markers as a guide to evaluate response to antiretroviral therapy. Curr Med Chem 2003, 10:349-365.
6. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
7. Garrigue I, Pellegrin I, Hoen B, Dumon B, Harzic M, Schrive MH, Sereni D, Fleury H: Cell-associated HIV-1 DNA quantification after HAART-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA. AIDS 2000, 14:2851-2855.
8. Ngo-Giang-Huong N, Deveau C, Da Silva I, Pellegrin I, Venet A, Harzic M, Sinet M, Delfraissy JF, Meyer L, Goujard C, Rouzioux C, Frnech PRIMO Cohort Study Group: Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after year of highly active antiretroviral therapy. French PRIMO Cohort Study Group. AIDS 2001, 15:665-673.
9. Pellegrin I, Caumont A, Garrigue I, Merel P, Schrive MH, Fleury H, Dupon M, Pellegrin JL, Ragnaud JM: Predictive Value of Provirus Load and DNA Human Immunodeficiency Virus Genotype for Successful Abacavir-Based Simplified Therapy. J Infect Dis 2003, 187:38-46.
10. Saitoh A, Hsia K, Fenton T, Powell CA, Christopherson C, Fletcher CV, Starr SE, Spector SA: Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children. J Infect Dis 2002, 15:1409-1416.
11. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD: Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
12. Aleman S, Visco-Comandini U, Lore K, Sönnerborg A: Long-term effects of antiretroviral combination therapy on HIV type 1 DNA levels. AIDS Res Hum Retroviruses 1999, 15:1249-54.
13. Hockett RD Jr, Saag MS, Kilby JM, Sfakianos G, Wakefield TB, Bucy RP: Stability in the HIV vDNA pool in peripheral CD4+ T cells of untreated patients by single tube quantitative PCR. J Virol Methods 2000, 87:1-12.
14. Kostrikis LG, Touloumi G, Karanicolas R, Pantazis N, Anastassopoulou C, Karafoulidou A, Goedert JJ, Hatzakis A, Multicenter Hemophilia Cohort Study Group: Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J Virol 2002, 76:10099-108.
15. Christopherson C, Kidane Y, Conway B, Krowka J, Sheppard H, Kwok S: PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells. J Clin Microbiol 2000, 38:630-634.
16. Comandini UV, Sönnerborg A, Vahlne A, Yun Z: Quantification of HIV-1 proviral DNA from peripheral blood mononuclear cells using a high throughput four-competitor competitive PCR. J Virol Methods 1997, 69:171-180.
17. Gratzl S, Moroni C, Hirsh HH: Quantification of HIV-1 viral RNA and proviral DNA by isotopic competitive PCR. J Virol Methods 1997, 66:269-282.
18. Guenthner PC, Hart CE: Quantitative, competitive PCR assay for HIV-1 using a microplate-based detection system. BioTechniques 1998, 24:810-816.
19. Izopet J, Tamalet C, Pasquier C, Sandres K, Marchou B, Massip P, Puel J: Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay. J Med Virol 1998, 54:54-59.
20. Jurriaans S, Dekker JT, de Ronde A: HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individuals. AIDS 1992, 6:635-641.
21. Stieger M, Démollière C, Ahlborn-Laake L, Mous J: Competitive polymerase chain reaction assay for quantification of HIV-1 DNA and RNA. J Virol Methods 1991, 34:149-160.
22. Zhao Y, Yu M, Miller JW, Chen M, Bremer EG, Kabat W, Yogev R: Quantification of Human Immunodeficiency Virus Type 1 Proviral DNA by Using TaqMan Technology. J Clin Microbiol 2002, 40:675-678.
23. Eriksson LE, Leitner T, Wahren B, Bostrom AC, Falk KI: A multiplex real-time PCR for quantification of HIV-1 DNA and the human albumin gene in CD4+ cells. APMIS 2003, 111:625-33.
24. Gibellini D, Vitone F, Schiavone P, Ponti C, Placa M, Carla Re M: Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. JCV 2004, 29:282-289.
25. Girard PM, Katlama Ch, Pialoux G: VIH. Paris: Doin 2001.
26. The Entrez Nucleotides database [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Nucleotide]
27. Cheingsong-Popov R, Osmanov S, Pau CP, Schochetman G, Barin F, Holmes H, Francis G, Ruppach H, Dietrich U, Lister S, Weber J: Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization. AIDS Res Hum Retroviruses 1998, 14:311-318.
28. Folks TM, Powell D, Lightfoote M, Koenig S, Fauci AS, Benn S, Rabson A, Daugherty D, Gendelman HE, Hoggan MD: Biological and biochemical characterization of a cloned Leu-3-cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 1986:280-90.
29. Alizon M, Wain-Hobson S, Montagnier L, Sonigo P: Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell 1986, 46:63-74.
30. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey MA, Santos-Ferreira MO, Laurent AG, Dauguet C, Katlama C, Rouzioux C: Isolation of a new human retrovirus from West African patients with AIDS. Science 1986, 233:343-346.
31. Guyader M, Emerman M, Sonigo P, Clavel F, Montagnier L, Alizon M: Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 1987, 326:662-669.
32. Rey MA, Krust B, Laurent AG, Guetard D, Montagnier L, Hovanessian AG: Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein. Virology 1989, 173:258-267.
33. Schmit JC, Cogniaux J, Hermans P, Van Vaeck C, Sprecher S, Van Remoortel B, Witvrouw M, Balzarini J, Desmyter J, De Clercq E, Vandamme AM: Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain. J Infect Dis 1996, 174:962-968.
34. Advanced Biological Laboratories S.A [http://www.ablnetworks.org/viroscorer/virosc_1.html]